YuanMing Capital
Asia, Beijing, China, Haidian'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments.
Investor Profile
YuanMing Capital has made 7 investments, with 1 in the past 12 months and 14% as lead.
Stage Focus
- Series A (29%)
- Private Equity (14%)
- Series D (14%)
- Series B (14%)
- Series F (14%)
- Seed (14%)
Country Focus
- China (71%)
- United States (29%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Therapeutics
- Biopharma
- Oncology
- Clinical Trials
- Manufacturing
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
